Home
Novavax NVAX paid Crossroads Strategies $50K for lobbying in Q2 2023 · Health Issues
Trade details
- Type
- Lobbying report
- Amount
- $50,000
- Quarter
- Q2 2023
- Stock
- Novavax NVAX
- Client
- Novavax
- Reported
- 23/07/19
Up 0.0% from last quarter
What else happened in Novavax around then
Filed or reported within 30 days of the trade day · 23/05/31~23/07/30Novavax's other lobbying reports
- Novavax
LobbyingNovavax
LobbyingNovavax
NVAX
$130K
$130K
Reported 07/17
for Q2
- Novavax
LobbyingNovavax
LobbyingNovavax
NVAX
$50K
$50K
Reported 07/16
for Q2
- Novavax
LobbyingNovavax
LobbyingNovavax
NVAX
$50K
$50K
Reported 07/15
for Q2
- Novavax
LobbyingNovavax
LobbyingNovavax
NVAX
$140K
$140K
Reported 04/20
for Q1
- Novavax
LobbyingNovavax
LobbyingNovavax
NVAX
$50K
$50K
Reported 04/16
for Q1